Post-orchiectomy miR-371 predicts recurrence in clinical stage I testicular germ cell tumours during active surveillance

Real-world outcomes after post-Lu177 therapy in mCRPC show limited survival and heterogeneous treatment patterns

Evaluation and definition of response and progression from trials to clinical practice

FX-909 shows tumour regression in PPARG-high advanced urothelial carcinoma

Enfortumab vedotin and pembrolizumab improves EFS, OS, and pCR in muscle-invasive bladder cancer

Climate and environmental factors drive seasonal risk of invasive mucormycosis in haematologic malignancies

Extreme heat exposure around diagnosis is linked to higher mortality in multiple myeloma

Can public–private partnerships accelerate cancer research and clinical trials in LMICs?

FFX/bevacizumab plus atezolizumab improves PFS in first-line dMMR/MSI-H mCRC

Immunoprevention and early detection of lung cancer in Africa: The LUNG-GUARD Platform

Advancing clinical trials in Africa

Exploring genetic essentiality and drug sensitivity in triple-negative breast cancer